CHINA FDA MEDICAL DEVICES TECHNOLOGY CHINESE MARKET FDA

Biomedicine emerging as zone's pillar industry

Author:Shi Jing Addtime:2018-12-28 Hit:1057

After five years of development at the China-Singapore Suzhou Industrial Park, Innomed Medical Device plans to bring one of its guide wire products - widely used in cardiovascular operations - to major Chinese hospitals in the first quarter of next year.

Innomed expects to mass produce the guide wire from next year, and will expand its current 1,600-square-meter plant area to 3,000 sq m in 2019, said Gong Xiaoyan, founder and CEO of Innomed.

Gong set up the company at Suzhou Industrial Park in 2013, hoping to localize the production of certain interventional and implantable medical devices. The ultimate goal is to break the monopoly of imported cardiovascular guide wires in the Chinese market, he said.

(China Dialy)